CTT PHARMACEUTICAL HOLDINGS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-20.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2012-03-20
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2011-12-31 was $0.00.
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2011-09-30 was $0.00.
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2010-12-31 was -$40.17K.
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2010-09-30 was -$424.92K.
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2011 was $0.00.
- CTT PHARMACEUTICAL HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2010 was -$495.45K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | $0.00 derived: sum of 2 quarters · filed 2012-03-20 | $0.00 10-K · filed 2012-03-20 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2010-12-31 | -$40.17K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | -$465.09K derived: sum of 2 quarters · filed 2012-03-20 | -$466.42K derived: sum of 3 quarters · filed 2012-03-20 | -$495.45K 10-K · filed 2012-03-20 |
| 2010-09-30 | -$424.92K 10-Q · filed 2011-11-14 | -$426.25K derived: sum of 2 quarters · filed 2011-11-14 | -$455.28K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | -$1.33K 10-Q · filed 2011-08-11 | -$30.36K 10-Q · filed 2011-08-11 |